FINWIRES · TerminalLIVE
FINWIRES

Halozyme Therapeutics Insider Sold Shares Worth $6,275,592, According to a Recent SEC Filing

By

Helen Torley, Director, President and Chief Executive Officer, on August 17, 2026, sold 60,000 shares in Halozyme Therapeutics (HALO) for $6,275,592. Following the Form 4 filing with the SEC, Torley has control over a total of 767,780 common shares of the company, with 767,780 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000115903626000108/xslF345X05/wk-form4_1787184072.xml

Related Articles